AI boosts breast cancer detection by 10.4% in UK screening evaluation

The UK’s first comprehensive evaluation of the use of Artificial Intelligence (AI) in breast cancer screening found that it can increase breast cancer detection by 10.4% and has the potential to reduce the workload of health care workers by more than 30% compared to the current clinical process. Published today in Nature Cancer, the evaluation was carried out by a team of scientists, clinicians and software developers from the University of Aberdeen, NHS Grampian, and Kheiron Medical Technologies, now part of DeepHealth Inc.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup